Microneedle patch-based enzyme-linked immunosorbent assay to quantify protein biomarkers of tuberculosis

Youngeun Kim,Mary Beth Lewis,Jihyun Hwang,Zheyu Wang,Rohit Gupta,Yuxiong Liu,Tuhina Gupta,James P. Barber,Srikanth Singamaneni,Fred Quinn,Mark R. Prausnitz
DOI: https://doi.org/10.1007/s10544-024-00694-2
2024-01-31
Biomedical Microdevices
Abstract:There is a clinical need for differential diagnosis of the latent versus active stages of tuberculosis (TB) disease by a simple-to-administer test. Alpha-crystallin (Acr) and early secretory antigenic target-6 (ESAT-6) are protein biomarkers associated with the latent and active stages of TB, respectively, and could be used for differential diagnosis. We therefore developed a microneedle patch (MNP) designed for application to the skin to quantify Acr and ESAT-6 in dermal interstitial fluid by enzyme-linked immunosorbent assay (ELISA). We fabricated mechanically strong microneedles made of polystyrene and coated them with capture antibodies against Acr and ESAT-6. We then optimized assay sensitivity to achieve a limit of detection of 750 pg/ml and 3,020 pg/ml for Acr and ESAT-6, respectively. This study demonstrates the feasibility of an MNP-based ELISA for differential diagnosis of latent TB disease.
engineering, biomedical,nanoscience & nanotechnology
What problem does this paper attempt to address?